XML 103 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Income (USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Net Sales $ 59,985 $ 53,674 $ 44,875
Cost of sales 51,029 45,780 39,148
Research and development expenses 1,646 1,660 1,492
Selling, general and administrative expenses 2,788 2,609 2,487
Amortization of intangibles 496 509 399
Goodwill impairment loss 0 0 7 [1]
Restructuring charges 0 26 [2] 689 [2]
Purchased in-process research and development charge 0 0 7 [3]
Acquisition and integration related expenses 31 [4] 143 [4] 166 [4]
Asbestos-related credit 0 54 [5] 0
Equity in earnings of nonconsolidated affiliates 1,223 1,112 630
Sundry income (expense) - net (316) 125 891
Interest income 40 37 39
Interest expense and amortization of debt discount 1,341 1,473 1,571
Income from Continuing Operations Before Income Taxes 3,601 2,802 469
Provision (Credit) for income taxes 817 481 (97)
Net Income from Continuing Operations 2,784 2,321 566
Income from discountinued operations, net of income taxes 0 0 110
Net Income 2,784 2,321 676
Net income attributable to noncontrolling interests 42 11 28
Net Income attributable to The Dow Chemical Company 2,742 2,310 648
Preferred stock dividends 340 340 312
Net Income Available for The Dow Chemical Company Common Stockholders $ 2,402 $ 1,970 $ 336
Per Common Share Data:      
Net income from continuing operations available for common stockholders (in dollars per share) $ 2.06 $ 1.75 $ 0.22
Discountinued operations attributable to common stockholders (in dollars per share) $ 0.00 $ 0.00 $ 0.10
Earnings per common share - basic (in dollars per share) $ 2.06 $ 1.75 $ 0.32
Net income from continuing operations available for common stockholders (in dollars per share) $ 2.05 $ 1.72 $ 0.22
Discountinued operations attributable to common stockholders (in dollars per share) $ 0.00 $ 0.00 $ 0.10
Earnings per common share - diluted (in dollars per share) $ 2.05 $ 1.72 $ 0.32
Common stock dividends declared per share of common stock $ 0.90 $ 0.60 $ 0.60
Weighted-average common shares outstanding - basic 1,149.0 1,125.9 1,043.2
Weighted-average common shares outstanding - diluted 1,158.2 1,143.8 1,053.9
[1] See Note I for information regarding the goodwill impairment loss.
[2] See Note C for information regarding restructuring charges.
[3] See Note D for information regarding purchased in-process research and development.
[4] See Note D for information regarding acquisition and integration related expenses.
[5] See Note N for information regarding the asbestos-related credit.